Pulse Biosciences, Inc. (PLSE) P/E Ratio History
Historical price-to-earnings valuation from 2026 to 2026
Loading P/E history...
PLSE Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Pulse Biosciences, Inc. (PLSE) trades at a price-to-earnings ratio of -17.7x, with a stock price of $19.08 and trailing twelve-month earnings per share of $-1.08.
Compared to the Healthcare sector median P/E of 22.2x, PLSE trades at a 180% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 176.0x.
Relative to the broader market, PLSE trades at a notable discount to the S&P 500 median P/E of 24.9x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PLSE DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
PLSE P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 6.9Lowest | 0.67 | +817%Best | |
| $884M | 9.8 | 0.98 | -36% | |
| $98B | 21.1 | - | +31% | |
| $80B | 27.8 | - | +55% | |
| $147B | 11.0 | 0.37Best | +134% | |
| $109B | 34.0 | 2.29 | +8% | |
| $160B | 57.2 | 2.63 | +23% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
See PLSE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PLSE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PLSE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPLSE — Frequently Asked Questions
Quick answers to the most common questions about buying PLSE stock.
Is PLSE stock overvalued or undervalued?
PLSE current P/E: -17.7x. 5-year average P/E: N/A. Percentile: N/A.
How does PLSE's valuation compare to peers?
Pulse Biosciences, Inc. P/E of -17.7x compares to sector median of 22.2x. The discount suggests lower growth expectations or higher risk.
What is PLSE's PEG ratio?
PLSE PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2026-2026.